-
1
-
-
84881426347
-
Finding the right antibody for the job
-
Marx V. Finding the right antibody for the job. Nat Methods 2013;8:703-7
-
(2013)
Nat Methods
, vol.8
, pp. 703-707
-
-
Marx, V.1
-
2
-
-
58149084454
-
Commercial antibodies: The good, bad, and really ugly
-
Couchman Jr. Commercial antibodies: The good, bad, and really ugly. J Histochem Cytochem 2009;57:7-8
-
(2009)
J Histochem Cytochem
, vol.57
, pp. 7-8
-
-
Couchman, J.R.1
-
3
-
-
58149089976
-
A guide to the perplexed on the specificity of antibodies
-
Saper CB. A guide to the perplexed on the specificity of antibodies. J Histochem Cytochem 2009;57:1-5
-
(2009)
J Histochem Cytochem
, vol.57
, pp. 1-5
-
-
Saper, C.B.1
-
4
-
-
55049112492
-
A genecentric Human Protein Atlas for expression profiles based on antibodies
-
Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, et al. A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics 2008;7:2019-27
-
(2008)
Mol Cell Proteomics
, vol.7
, pp. 2019-2027
-
-
Berglund, L.1
Björling, E.2
Oksvold, P.3
Fagerberg, L.4
Asplund, A.5
Szigyarto, C.A.6
-
5
-
-
0037176562
-
Unreliable immunoassays, patients' safety, and clinical research [7] (multiple letters)
-
Lindstedt G, Frändberg S. Unreliable immunoassays, patients' safety, and clinical research. Lancet 2002;26:356-7 (Pubitemid 34119311)
-
(2002)
Lancet
, vol.359
, Issue.9303
, pp. 356-357
-
-
Lindstedt, G.1
Frandberg, S.2
Koziarz, J.J.3
-
6
-
-
84867009373
-
Commercial immunoassays in biomarkers studies: Researchers beware!
-
Rifai N, Watson ID, Miller G. Commercial immunoassays in biomarkers studies: researchers beware! Clin Chem 2012;58:1387-8
-
(2012)
Clin Chem
, vol.58
, pp. 1387-1388
-
-
Rifai, N.1
Watson, I.D.2
Miller, G.3
-
7
-
-
84866483406
-
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans
-
Gutiérrez OM, Sun CC, Chen W, Babitt JL, Lin HY. Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans. Am J Nephrol 2012;36:332-3
-
(2012)
Am J Nephrol
, vol.36
, pp. 332-333
-
-
Gutiérrez, O.M.1
Sun, C.C.2
Chen, W.3
Babitt, J.L.4
Lin, H.Y.5
-
8
-
-
84893510877
-
False biomarker discovery due to reactivity of a commercial elisa for cuzd1 with cancer antigen CA125
-
(in press)
-
Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, et al. False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125. Clin Chem 2013;(in press)
-
(2013)
Clin Chem
-
-
Prassas, I.1
Brinc, D.2
Farkona, S.3
Leung, F.4
Dimitromanolakis, A.5
Chrystoja, C.C.6
-
10
-
-
77955815648
-
Characterizations and validations of novel antibodies toward translational research
-
Williams R, Chung JY, Ylaya K, Whiteley G, Hewitt SM. Characterizations and validations of novel antibodies toward translational research. Proteomics Clin Appl 2010;4:618-25
-
(2010)
Proteomics Clin Appl
, vol.4
, pp. 618-625
-
-
Williams, R.1
Chung, J.Y.2
Ylaya, K.3
Whiteley, G.4
Hewitt, S.M.5
-
11
-
-
77954062372
-
Antibody validation
-
Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, et al. Antibody validation. Biotechniques 2010;48:197-209
-
(2010)
Biotechniques
, vol.48
, pp. 197-209
-
-
Bordeaux, J.1
Welsh, A.2
Agarwal, S.3
Killiam, E.4
Baquero, M.5
Hanna, J.6
-
12
-
-
84872720767
-
Editorial: Antibody validation requirements for articles published in endocrinology
-
Gore AC. Editorial: Antibody validation requirements for articles published in endocrinology. Endocrinology 2013;154:579-80.
-
(2013)
Endocrinology
, vol.154
, pp. 579-580
-
-
Gore, A.C.1
|